Vizient, Inc. Announces Antitrust Clearance for MedAssets Acquisition





IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. (“Vizient”) today announces the expiration of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) in connection with the acquisition of MedAssets’ (NASDAQ: MDAS) Spend and Clinical Resource Management (SCM) segment, including Sg2, from Pamplona Capital Management (“Pamplona”). The expiration of the HSR waiting period satisfies one of the conditions to the closing of the pending acquisition, which remains subject to other customary closing conditions.

The combined expertise of Vizient and MedAssets’ SCM & Sg2 businesses will help health care providers significantly improve their financial, clinical and operational performance. The announcement builds on the decision earlier this year to bring VHA, UHC and Novation together to form Vizient, the nation’s largest member-owned health care company.

The transaction is anticipated to close by mid-February, pending the completion of Pamplona’s acquisition of MedAssets.

About Vizient, Inc.

Effective April 1, 2015, VHA Inc., the national health care network of not-for-profit hospitals, and UHC, the alliance of the nation’s leading academic medical centers, along with Novation, their health care contracting company, combined into a single organization – Vizient. Vizient is the largest member-owned health care company in the country and is dedicated to leading health care innovation, creating knowledge and fostering collaboration to help our members thrive. The company serves more than 5,200 health system and hospital members and affiliates as well as 167,000 non-acute health care customers. Members range from independent, community-based health care organizations to large, integrated systems and academic medical centers, and it represents more than $60 billion in annual purchasing volume. Headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States.


Vizient, Inc.
Angie Boliver, 972-830-7961

Related Materials